600276.SS

Healthcare Drug Manufacturers - Specialty & Generic

Jiangsu Hengrui Pharmaceuticals Co.,Ltd

CN¥47.20

+1.58 +3.46% today

Price History

Not enough data

Key Stats

Market Cap

313.28B

Avg Volume

86.59M

P/E (TTM)

40.69

EPS

CN¥1.16

52W High

CN¥71.66

52W Low

CN¥41.89

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

30.66

P/B Ratio

5.03

P/S Ratio

9.62

EV/EBITDA

33.16

EV/Revenue

9.63

PEG Ratio

0.93

Margins

Gross Margin 86.3%

Operating Margin 31.6%

Net Margin 24.9%

EBITDA Margin 29.0%

Growth & Returns

Revenue Growth (YoY)

13.0%

Earnings Growth (YoY)

13.3%

Earnings Growth (QoQ)

21.8%

Return on Equity

14.5%

Return on Assets

8.8%

Liquidity & Leverage

Current Ratio

9.23

Quick Ratio

8.36

Debt / Equity

0.00

Total Cash

40.64B

Total Debt

67.47M

About

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.